|
Canada-0-BAILIFFS Azienda Directories
|
Azienda News:
- Drug Approvals and Databases | FDA
Downloadable data files FDA Adverse Event Reporting System (FAERS) Public Dashboard Inactive Ingredient Search for Approved Drug Products Search More information Medication Guides Search More
- FDA approves Denalis Hunter syndrome drug
The FDA has approved Denali Therapeutics’ enzyme replacement therapy for a genetic lysosomal storage disease after a string of high-profile rejections for rare disease candidates In approving
- New FDA Drug Approvals for 2026 - Drugs. com
Up to date information on the latest FDA drug approvals Includes list of most recent approvals, the conditions approved for, and the approval history
- FDA Approves Treatment for Serious Liver Disease Known as . . .
The U S Food and Drug Administration has approved Wegovy (semaglutide) injection to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis (excessive scar
- Denali Therapeutics Announces U. S. FDA Approval of AVLAYAH . . .
First new FDA-approved treatment option in nearly 20 years for families living with this rare lysosomal storage disease First FDA-approved medicine in emerging new class of biotherapeutics that leverage transferrin receptor to cross blood-brain barrier Denali’s first medicine enabled by its TransportVehicle™ platform designed to deliver biotherapeutics to whole body, including brain Rare
- FDA approves Wellcovorin for ultra-rare disease. The Trump . . .
The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease cerebral folate deficiency (CFD) in both children and adults, the same
- UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA . . .
"The FDA approval of UPLIZNA marks a significant turning point for IgG4-RD patients and physicians who now have a proven treatment that targets a key driver of the disease, reducing the risk of flares and reliance on harmful long-term steroid use," said Jay Bradner, M D , executive vice president of Research and Development at Amgen
- First approved drug for mitochondrial disease could pave way . . .
In addition, FDA only approved the drug for patients who weigh at least 30 kilograms, excluding newborns who may already be suffering from symptoms Two other clinical trials of mitochondrial disease drugs have adopted yet another endpoint
- AASLD Applauds FDA Approval of First GLP-1 Therapy for MASH . . .
The FDA’s decision to approve Wegovy provides clinicians with a long-awaited new therapeutic option for MASH, which according to the FDA, affects about 6% of adults, or nearly 15 million people The recent FDA approval of Wegovyw for MASH follows last year’s approval of Rezdiffra (resmetirom), the first drug to treat patients with the disease
- FDA-Approved Treatments for Alzheimers
FDA-Approved Drugs For Alzheimer's The FDA has approved medications that fall into two categories: drugs that change disease progression in people living with early Alzheimer's disease, and drugs that may temporarily mitigate some symptoms of Alzheimer's dementia
|
|